Aemetis, Inc. Advances in Renewable Natural Gas and Ethanol Production Amid Policy Tailwinds
August 15th, 2025 12:10 AM
By: Newsworthy Staff
Aemetis, Inc. showcases significant progress in its Dairy RNG platform and ethanol production, supported by regulatory approvals and favorable policy developments, positioning the company for high growth.

Aemetis, Inc. (Nasdaq: AMTX) has demonstrated notable advancements in its renewable natural gas (RNG) and ethanol production capabilities, as highlighted in the recent coverage update by Stonegate Capital Partners. The company's Dairy RNG platform is entering a high-growth phase, with eleven digesters producing 106,400 MMBtu of RNG in the quarter, generating $3.1M in revenue. This growth is further supported by the California Air Resources Board's (CARB) approval of seven new Low Carbon Fuel Standard (LCFS) pathways at a blended CI score of -384, which is expected to unlock approximately 120% more in LCFS credit value.
Capacity expansion is a key focus for Aemetis, with expectations to reach 550,000 MMBtus by the end of the year and further increase to 1.0M MMBtus by the end of 2026. The company's monetization strategies have diversified, now including the sale of RNG molecules, D3 RIN credits, LCFS production tax credits, and section 45Z production tax credits. Aemetis has already sold $83M in Section 48 investment tax credits, generating ~$70M in cash, with 45Z monetization expected to become a recurring quarterly revenue item starting in 3Q25.
In addition to RNG, Aemetis is making strides in its California Ethanol segment, with a $30M mechanical vapor recompression (MVR) system expected to reduce natural gas use by 80% and add $32M in annual cash flow starting in 2026. The company's India Biodiesel operations have resumed deliveries, contributing $11.9M in revenue, with an early 2026 IPO on track for its India subsidiary.
The second quarter of 2025 saw Aemetis reporting revenue of $52.2M, up $9.3M from 1Q25 but down from $66.6M in 2Q24, primarily due to lower year-over-year biodiesel volumes. However, the company has shown improvement in its operating loss, which narrowed to $10.7M from $13.6M year-over-year, with SG&A expenses decreasing by $4.5M sequentially. Net loss also improved to $23.4M from $29.2M.
Aemetis is well-positioned to benefit from several U.S. policy tailwinds, including CARB’s 20-year LCFS framework, Section 45Z Production Tax Credits, nationwide E15 expansion, and strong low-carbon fuel mandates and incentives. These developments are expected to accelerate demand for low-carbon fuels and support Aemetis's growth trajectory. The company's valuation, based on a Discounted Cash Flow Model, ranges from $8.30 to $18.77, with a midpoint of $12.39.
Source Statement
This news article relied primarily on a press release disributed by Reportable. You can read the source press release here,
